The Trump administration has cut funding for vaccine research since COVID-19 is not a pandemic but coronaviruses and ...
Its overdependence on vaccines leaves the country vulnerable to bioterrorism.
Federal officials cited the end of the Covid-19 pandemic in halting the research. But much of the work was focused on ...
H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to ...
With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...
Modified live vaccines tend to produce slightly stronger and longer lasting immunity and may provide slightly higher fetal ...
New computational modeling of avian influenza variants’ immunoprotein interactions – developed by a research team at the University of North Carolina at Charlotte – reveals the H5N1 influenza virus is ...
Most pediatric transplant recipients who received live-attenuated viral vaccines after transplant developed protective ...
Vaccine manufacturer Bharat Biotech International Limited (BBIL) is making a foray into the cell and gene therapy (CGT) space ...